Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.

Chakraborty, Debdulal; Sheth, Jay U; Boral, Subhendu; Sinha, Tushar K

Chakraborty, Debdulal; Sheth, Jay U; Boral, Subhendu; Sinha, Tushar K.

Afiliación

Chakraborty D; Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, India.
Sheth JU; Department of Vitreoretinal Services, Surya Eye Institute and Research Center, Mumbai, India.
Boral S; Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, India.
Sinha TK; Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, India.

Am J Ophthalmol Case Rep ; 24: 101197, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34504981

Palabras clave

Anti-vascular endothelial growth factor; Brolucizumab; Diabetic macular edema

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Am J Ophthalmol Case Rep Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google